Markets:

Overview

News

Currencies

International

Treasuries

Biogen Idec (NQ:BIIB)

167.55 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biogen Idec

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

56 57 Next >

7 Retirement Stocks to Buy at a 52-Week Low in April ↗

April 29, 2024

One of the best ways to keep your portfolio safe while generating income is with dividend-paying retirement stocks at 52-week lows.

Via InvestorPlace

Topics Retirement

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review ↗

April 26, 2024

Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.

Via Investor's Business Daily

These Analysts Revise Their Forecasts On Biogen After Q1 Results ↗

April 25, 2024

Via Benzinga

Where Biogen Stands With Analysts ↗

April 11, 2024

Via Benzinga

Looking Into Biogen's Recent Short Interest ↗

April 03, 2024

Via Benzinga

Forecasting The Future: 18 Analyst Projections For Biogen ↗

March 25, 2024

Via Benzinga

Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday ↗

April 25, 2024

Via Benzinga

Why Biogen Stock Leaped Nearly 5% Higher Today ↗

April 24, 2024

The company came out swinging with its first set of quarterly earnings for this year.

Via The Motley Fool

Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why ↗

April 24, 2024

Discover the challenges facing Leqembi, the first Alzheimer's drug shown to slow progression. Skepticism among doctors and concerns about efficacy and costs hinder widespread adoption despite FDA...

Via Benzinga

Biogen (BIIB) Q1 2024 Earnings Call Transcript ↗

April 24, 2024

BIIB earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings ↗

April 24, 2024

Biogen reports Q1 results: adjusted EPS $3.67 (beat consensus), sales $2.29 billion (missed consensus). Leqembi launch uptake triples, Zurzuvae's early trends encouraging.

Via Benzinga

Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday? ↗

April 24, 2024

Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the...

Via Benzinga

Topics Bonds

BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024 ↗

April 24, 2024

BIIB stock results show that Biogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline? ↗

April 24, 2024

Biogen shares have lost nearly 40% of their value since last June. Could two key sales beats help revive shares?

Via Investor's Business Daily

Topics Earnings

Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally ↗

April 24, 2024

Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 09, 2024

Via Benzinga

10 Big-Name Stocks Near 52 Week Lows: Are They A Buy? ↗

March 29, 2024

Over the past twelve months, a number of big-name companies have been near or below their 52-week low price. Each week we’ll take a look at some of the biggest names currently close to their 52-week...

Via Talk Markets

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week ↗

April 21, 2024

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

Via Benzinga

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback ↗

March 28, 2024

The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.

Via Investor's Business Daily

Tuesday Talk: Big-Tech Under Attack ↗

March 26, 2024

On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.

Via Talk Markets

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗

March 25, 2024

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

Via InvestorPlace

European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab ↗

March 22, 2024

Biogen and Eisai face delays as EMA postpones the oral explanation for the lecanemab review. Procedural issues at EMA prompt setback, impacting drug evaluation process amid recent EU court ruling.

Via Benzinga

Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 21, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 20, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 19, 2024

Via Benzinga

10 Big-Name Stocks Near 52-Week Lows: Are They A Buy? ↗

March 16, 2024

Over the past twelve months a number of big named companies have been near or below their 52 week low price. Each week we’ll take a look at some of the biggest names currently close to their 52 week...

Via Talk Markets

Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 14, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Fed Rate Cut Expectations Rise After February Jobs Report: Friday's Stock Movers ↗

March 08, 2024

February labor report shows mixed signals: increase in non-farm payrolls but higher unemployment rate and downward revisions. Wage growth lower than expected, fueling bets on Fed rate cuts. Stocks...

Via Benzinga

Topics Economy

Are These 5 Undervalued Stocks Ready to Break Out?

March 08, 2024

Undervalued stocks Albemarle, Ionis, Insulet, Hess and Wynn beat earnings views, offering potential for investors to buy quality companies at discounted prices.

Via MarketBeat

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Biogen Idec (NQ:BIIB)

All News about Biogen Idec

Starting at $3.75/week.

Subscribe Today